📰 Leukemia Unit News
Leukemia Unit News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia Unit. Real-time updates on events, politics, business and more.
April 3, 2024
Approval of Reblozyl is based on head-to-head, pivotal Phase 3 COMMANDS study, in which Reblozyl nearly doubled the percentage of patients achieving transfusion independence and hemoglobin increase,...
June 19, 2023
Trial results demonstrated that 58.5% of individuals receiving luspatercept-aamt (Reblozyl; Bristol Myers Squibb) achieved the primary endpoint of red blood cell transfusion independence of at least 12 weeks.
May 25, 2023
Results from Phase 3 COMMANDS study, selected for ASCO’s official press program, show nearly twice as many patients treated with Reblozyl achieved superior transfusion independence with... | May 25, 2023
May 25, 2023
Results from Phase 3 COMMANDS study, selected for ASCO's official press program, show nearly twice as many patients treated with Reblozyl achieved superior transfusion independence with concurrent
March 29, 2023
Preliminary results for the pharmaceutical revumenib suggest that it may have saved lives of terminal patients, including the young architect Algimante Daugelaite
October 28, 2022
Eight out of the nine children who were seriously ill have recovered, according to the Health Minister amid calls for lifting the US-backed Saudi blockade on the entry of drugs including those for cancer patients.